Saturn V Capital Management LP Diversified Active

CIK: 0001964437 · Show all filings

Period: Q4 2025 (← Previous)

Filing Date: Feb 17, 2026

Total Value ($000): $544,901 (100.0% shares, 0.0% debt)

Holdings (20)

New Positions (8)

ALMS ALUMIS INC 5.6%

Value ($000) $30,607 Shares 3,135,953 Est. Cost $6.98 Unrealized 0.0%

XFOR X4 PHARMACEUTICALS INC 4.3%

Value ($000) $23,202 Shares 5,800,530 Est. Cost $3.63 Unrealized 0.0%

IVVD INVIVYD INC 3.5%

Value ($000) $19,106 Shares 7,735,386 Est. Cost $2.08 Unrealized 0.0%

IMMX IMMIX BIOPHARMA INC 2.9%

Value ($000) $15,686 Shares 2,999,169 Est. Cost $4.12 Unrealized 0.0%

OCS OCULIS HOLDING AG 1.9%

Value ($000) $10,320 Shares 516,761 Est. Cost $20.00 Unrealized 0.0%

IKT INHIBIKASE THERAPEUTICS INC 1.5%

Value ($000) $7,906 Shares 3,856,799 Est. Cost $1.59 Unrealized 0.0%

OVID OVID THERAPEUTICS INC 0.7%

Value ($000) $4,075 Shares 2,500,000 Est. Cost $1.54 Unrealized 0.0%

IVA INVENTIVA SA 0.2%

Value ($000) $1,317 Shares 283,166 Est. Cost $4.65 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ALMS	ALUMIS INC	3,135,953	$30,607	5.6%	$6.98	0.0%	COM	022307102
XFOR	X4 PHARMACEUTICALS INC	5,800,530	$23,202	4.3%	$3.63	0.0%	COM NEW	98420X202
IVVD	INVIVYD INC	7,735,386	$19,106	3.5%	$2.08	0.0%	COM	00534A102
IMMX	IMMIX BIOPHARMA INC	2,999,169	$15,686	2.9%	$4.12	0.0%	COM	45258H106
OCS	OCULIS HOLDING AG	516,761	$10,320	1.9%	$20.00	0.0%	ORDINARY SHARES	H5870P102
IKT	INHIBIKASE THERAPEUTICS INC	3,856,799	$7,906	1.5%	$1.59	0.0%	COM NEW	45719W205
OVID	OVID THERAPEUTICS INC	2,500,000	$4,075	0.7%	$1.54	0.0%	COM	690469101
IVA	INVENTIVA SA	283,166	$1,317	0.2%	$4.65	—	ADS	46124U107

Increased Positions (4)

PHVS PHARVARIS N V 5.8%

Value ($000) $31,636 (+43.1%) Shares 1,140,033 (+28.6%) Est. Cost $22.60 Unrealized +6.6%

MNPR MONOPAR THERAPEUTICS INC 3.9%

Value ($000) $21,268 (+67.6%) Shares 325,701 (+109.6%) Est. Cost $64.05 Unrealized +27.6%

PCVX VAXCYTE INC 6.8%

Value ($000) $36,863 (+29.8%) Shares 798,940 (+1.3%) Est. Cost $43.98 Unrealized +1.7%

OCUL OCULAR THERAPEUTIX INC 3.4%

Value ($000) $18,269 (+35.7%) Shares 1,504,880 (+30.7%) Est. Cost $10.21 Unrealized +19.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
PHVS	PHARVARIS N V	1,140,033 (+28.6%)	$31,636 (+43.1%)	5.8%	$22.60	+6.6%	COM	N69605108
MNPR	MONOPAR THERAPEUTICS INC	325,701 (+109.6%)	$21,268 (+67.6%)	3.9%	$64.05	+27.6%	COM NEW	61023L207
PCVX	VAXCYTE INC	798,940 (+1.3%)	$36,863 (+29.8%)	6.8%	$43.98	+1.7%	COM	92243G108
OCUL	OCULAR THERAPEUTIX INC	1,504,880 (+30.7%)	$18,269 (+35.7%)	3.4%	$10.21	+19.0%	COM	67576A100

Exited Positions (5)

CGON CG ONCOLOGY INC 4.3%

Value ($000) $23,358 Shares 579,895 Est. Cost $34.79 Unrealized +19.0%

XENE XENON PHARMACEUTICALS INC 3.7%

Value ($000) $20,224 Shares 503,701 Est. Cost $39.36 Unrealized +6.7%

— MERUS N V 3.2%

Value ($000) $17,336 Shares 184,135 Est. Cost $35.99 Unrealized —

LENZ LENZ THERAPEUTICS INC 3.1%

Value ($000) $17,150 Shares 368,176 Est. Cost $27.87 Unrealized +4.6%

NAMS NEWAMSTERDAM PHARMA COMPANY 0.8%

Value ($000) $4,356 Shares 153,147 Est. Cost $19.89 Unrealized +82.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGON	CG ONCOLOGY INC	579,895	$23,358	4.3%	$34.79	+19.0%	—	156944100
XENE	XENON PHARMACEUTICALS INC	503,701	$20,224	3.7%	$39.36	+6.7%	—	98420N105
—	MERUS N V	184,135	$17,336	3.2%	$35.99	—	—	N5749R100
LENZ	LENZ THERAPEUTICS INC	368,176	$17,150	3.1%	$27.87	+4.6%	—	52635N103
NAMS	NEWAMSTERDAM PHARMA COMPANY	153,147	$4,356	0.8%	$19.89	+82.9%	—	N62509109

Decreased Positions (8)

ABVX ABIVAX SA 16.1%

Value ($000) $87,545 (+28.7%) Shares 649,179 (-19.0%) Est. Cost $29.41 Unrealized —

COGT COGENT BIOSCIENCES INC 7.9%

Value ($000) $43,230 (+48.7%) Shares 1,217,064 (-39.9%) Est. Cost $7.59 Unrealized +270.2%

CNTA CENTESSA PHARMACEUTICALS PLC 1.3%

Value ($000) $7,070 (-60.3%) Shares 282,692 (-61.5%) Est. Cost $13.84 Unrealized —

AMLX AMYLYX PHARMACEUTICALS INC 10.0%

Value ($000) $54,318 (-13.2%) Shares 4,496,487 (-2.4%) Est. Cost $5.73 Unrealized +137.2%

CELC CELCUITY INC 5.8%

Value ($000) $31,627 (+35.1%) Shares 317,095 (-33.1%) Est. Cost $15.84 Unrealized +418.9%

JAZZ JAZZ PHARMACEUTICALS PLC 7.7%

Value ($000) $42,172 (+6.4%) Shares 248,070 (-17.5%) Est. Cost $112.15 Unrealized +36.7%

IRON DISC MEDICINE INC 4.3%

Value ($000) $23,698 (+5.2%) Shares 298,429 (-12.5%) Est. Cost $47.97 Unrealized +76.1%

DYN DYNE THERAPEUTICS INC 6.4%

Value ($000) $34,985 (+3.4%) Shares 1,788,616 (-33.1%) Est. Cost $11.19 Unrealized +69.2%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ABVX	ABIVAX SA	649,179 (-19.0%)	$87,545 (+28.7%)	16.1%	$29.41	—	SPONSORED ADS	00370M103
COGT	COGENT BIOSCIENCES INC	1,217,064 (-39.9%)	$43,230 (+48.7%)	7.9%	$7.59	+270.2%	COM	19240Q201
CNTA	CENTESSA PHARMACEUTICALS PLC	282,692 (-61.5%)	$7,070 (-60.3%)	1.3%	$13.84	—	SPONSORED ADS	152309100
AMLX	AMYLYX PHARMACEUTICALS INC	4,496,487 (-2.4%)	$54,318 (-13.2%)	10.0%	$5.73	+137.2%	COM	03237H101
CELC	CELCUITY INC	317,095 (-33.1%)	$31,627 (+35.1%)	5.8%	$15.84	+418.9%	COM	15102K100
JAZZ	JAZZ PHARMACEUTICALS PLC	248,070 (-17.5%)	$42,172 (+6.4%)	7.7%	$112.15	+36.7%	SHS USD	G50871105
IRON	DISC MEDICINE INC	298,429 (-12.5%)	$23,698 (+5.2%)	4.3%	$47.97	+76.1%	COM	254604101
DYN	DYNE THERAPEUTICS INC	1,788,616 (-33.1%)	$34,985 (+3.4%)	6.4%	$11.19	+69.2%	COM	26818M108